Capital Analysts, LLC: DFIV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Analysts, LLC on DFIV, newest first. How the timeline and the estimate are built.
Capital Analysts, LLC held 423,550 DFIV shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 423,550 sharesChange vs previous 13F +26,979 shares
0.51% of the 13F portfolio, value $23,659,517.
13F-HR 0001624758-26-000047 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-06-3013F/A 396,571 sharesChange vs previous 13F +31,709 shares
0.49% of the 13F portfolio, value $21,422,755.
13F-HR/A 0001624758-26-000016 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-03-3113F/A 364,862 sharesChange vs previous 13F +6,323 shares
0.51% of the 13F portfolio, value $19,257,418.
13F-HR/A 0001624758-26-000018 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-12-3113F/A 358,539 sharesChange vs previous 13F +13,918 shares
0.5% of the 13F portfolio, value $17,891,108.
13F-HR/A 0001624758-26-000020 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-09-3013F/A 344,621 sharesChange vs previous 13F +60,810 shares
0.46% of the 13F portfolio, value $15,893,894.
13F-HR/A 0001624758-26-000022 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-06-3013F/A 283,811 sharesChange vs previous 13F +117,308 shares
0.41% of the 13F portfolio, value $12,155,620.
13F-HR/A 0001624758-26-000024 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-03-3113F/A 166,503 sharesChange vs previous 13F +111,576 shares
0.24% of the 13F portfolio, value $6,553,555.
13F-HR/A 0001624758-26-000026 filed by Capital Analysts, LLC
Accepted , ingested - period ended2024-12-3113F/A 54,927 sharesChange vs previous 13F not available
0.08% of the 13F portfolio, value $1,948,806.
13F-HR/A 0001624758-26-000028 filed by Capital Analysts, LLC
Accepted , ingested